Natalia Muñoz-Durango

Natalia Muñoz-Durango

Auto-generated profile, based on publicly available information

Natalia Muñoz-Durango

Directora de Proyectos Especiales, VaxThera S.A.S., Medellín, Colombia

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2020 in Molecular Oncology
Verified
Journal Article
Open access
PDF file
LRLorena Rosa
Lorena Rosa
lorena Lobos-Gonzalezlorena Lobos-Gonzalez
lorena Lobos-Gonzalez
NMNatalia Muñoz‐Durango
Natalia Muñoz‐Durango
PGPatricia Garcia
Patricia Garcia
CBCarolina Bizama
Carolina Bizama
Juan Carlos RoaJuan Carlos Roa
Juan Carlos Roa
Gallbladder stones (cholecystolithiasis) are the main risk factor for gallbladder cancer (GBC), a lethal biliary malignancy with poor survival rates worldwide. Gallbladder stones are thought to damage the gallbladder epithelium and trigger chronic inflammation. Preneoplastic lesions that arise in such an inflammatory microenvironment can eventually develop into invasive carcinoma, through mechanisms that are not fully understood. Here, we developed a novel gallbladder preneoplasia mouse model through the administration of two lithogenic diets (a low‐ or a high‐cholesterol diet) in wild‐type C57BL/6 mice over a period of 9 months. Additionally, we evaluated the chemopreventive potentials of the anti‐inflammatory drug aspirin and the cholesterol absorption inhibitor ezetimibe. Both lithogenic diets induced early formation of gallbladder stones, together with extensive inflammatory changes and widespread induction of metaplasia, an epithelial adaptation to tissue injury. Dysplastic lesions were presented only in mice fed with high‐cholesterol diet (62.5%) in late stages (9th month), and no invasive carcinoma was observed at any stage. The cholesterol absorption inhibitor ezetimibe inhibited gallbladder stone formation and completely prevented the onset of metaplasia and dysplasia in both lithogenic diets, whereas aspirin partially reduced metaplasia development only in the low‐cholesterol diet setting. This model recapitulates several of the structural and inflammatory findings observed in human cholecystolithiasic gallbladders, making it relevant for the study of gallbladder carcinogenesis. In addition, our results suggest that the use of cholesterol absorption inhibitors and anti‐inflammatory drugs can be evaluated as chemopreventive strategies to reduce the burden of GBC among high‐risk populations.

30 May 2025 in Biomédica
Verified
Journal Article
Open access
PDF file
NMNatalia Muñoz-Durango
Natalia Muñoz-Durango
JHJuan P Hernandez-Ortiz
Juan P Hernandez-Ortiz
JOJorge E. Osorio
Jorge E. Osorio